Au sommaire de ce numéro :

Les Références MICI incontournables et les guidelines

Les MICI dans les différents Congrès :
Comptes rendus par les membres de la commission MICI

• Les MICI à l’UEWG 2003
• Les MICI au 6e symposium IBD 2003
• Les MICI aux Journées Francophones 2004
• Les MICI à l’AGA 2004

Les Résumés des Références MICI essentielles des 12 derniers mois

• NORGARD B., FONAGER K., PEDERSEN L., JACOBSEN B.A., SORENSEN H.T. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003; 52:243-247
• HERRERIAS J.M., CAUNEDO A., RODRIGUEZ-TELLEZ M., PELLICER F., HERRERIAS J.M. Jr. Capsule endoscopy in patients with suspected Crohn’s disease and negative endoscopy. Endoscopy 2003; 35:564-568
• BIANCONE L., FIORI R.,TOSTI C., MARINETTI A., CATARINACCI M., DE NIGRIS F., SIMONETTI G., PALLONE F. Virtual colonoscopy compared with conventional colonoscopy for stricturing postoperative recurrence in Crohn’s disease. Inflamm Bowel Dis 2003; 9:343-350
• MESSMANN H., ENDLICHER E., FREUNEK G., RUMMELE P., SCHOLMERICH J., KNUCHEL R. Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation. Gut 2003; 52:1003-1007
• FOSTER R.A., ZANDER D.S., MERGO P.J.,VALENTINE J.F. Mesalamine-Related Lung Disease: Clinical, Radiographic, and Pathologic Manifestations. Inflammatory Bowel Dis 2003; 9:308-315
• RYAN B.M., RUSSEL M.G.V.M., LANGHOLZ E., STOCKBRUGGER R.W. Aminosalicylates and Colorectal Cancer in IBD: A Not-So Bitter Pill to Swallow. Am J Gastroenterol 2003; 98:1682-1687
• SUMMERS R.W., ELLIOTT D.E., QADIR K., URBAN J.F. Jr, THOMPSON R., WEINSTOCK J.V. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 2003; 98:2034-2041
• ULLMAN T., CROOG V., HARPAZ N., SACHAR D., ITZKOWITZ S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003; 125:1311-1319
• MANGUSO F., SANGES P.D.M., STAIANO T., GARGIULO S., NASTRO P., GARGANO D., SOMMA P.,MANSUETO G., PELUSO R., SCARPA R., D’ARMIENTO F.P., ASTARITA P.D.C., AYALA F., RENDA A., MAZZACCA G., D’ARIENZO A. Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterol 2004; 327-334
• LICHTENSTEIN G.R.,YAN S., BALA M., HANAUER S. Remission in patients with Crohn’s disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol 2004; 99: 91-96
• DE JONG D.J., GOULLET M., NABER T.H. Side effects of azathioprine in patients with Crohn’s disease. Eur J Gastroenterol Hepatol 2004; 16:207-212
• LOFTUS JR E.V., KANE S.V., BJORKMAN D. Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2004; 19:179-189
• HUNTER M.M., MCKAY D.M. Review article: helminths as therapeutic agents for inflammatory bowel disease. Aliment Pharmacol Ther 2004; 19:167-177
• BIANCONE L.,TOSTI C., GEREMIA A., FINA D., PETRUZZIELO C., EMERENZIANI S., PALLONE F. Rofecoxib and ealy relapse of inflammatory bowel disease: an openlabel trial. Aliment Pharmacol Ther 2004; 19:755-764
• REINISCH W., MIEHSLER W., DEJACO C., HARRER M., WALDHOER T., LICHTENBERGER C., VOGELSANG H. An open-label trial of the selective cyclo-oxygenaseinhibitor, rofecoxib, in inflammatory bowel diseaseassociated periperical arthritis and arthralgias. Aliment Pharmacol Ther 2003; 17:1371-1380
• WRIGHT S., SANDERS D.S., LOBO A.J., LENNARD L. Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease. Gut 2004; 53:1123-1128
• JOHNSON P., RICHARD C., RAVID A., SPENCER L., PINTO E.,HANNA M., COHEN Z.,MCLEOD R. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004; 47:1119-1126
• SANDBORN W.J., FAUBIONW.A. Biologics in inflammatory bowel disease: how much progress have we made? Gut 2004; 53:1366-1373
• HANAUER S.B., KORELITZ B.I., RUTGEERTS P., PEPPERCORN M.A., THISTED R.A., COHEN R.D., PRESENT D.H. Post-operative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine or placebo: A two-year trial. Gastroenterology 2004; 127:723- 729
• ARDIZZONE S., MACONI G., SAMPIETRO G.M., RUSSO A.G., RADICE E., COLOMBO E., IMBESI V., MOLTENI M., DANELLI P.G.,TASCHIERI A.M., PORRO G.B. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology 2004; 127:730-739